CliffBio
small molecule

GLOPERBA

COLCHICINE

Loss of exclusivityDecember 2037latest FDA-listed patent expiry
CompanyScilex Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameGLOPERBA
Active ingredientCOLCHICINE
Strength0.6MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2019
Marketing statusRX

Listed patents

PatentExpiresType
10226423December 2037product
12274751November 2036use U-2814
12514819November 2036use U-2814
10383820November 2036product
10383821November 2036product
9907751November 2036product

More from Scilex Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

GLOPERBA patent cliff — loss of exclusivity December 2037 | CliffBio